Detalhe da pesquisa
1.
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
Ann Surg Oncol;
24(7): 1853-1860, 2017 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27864694
2.
A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer.
J Natl Compr Canc Netw;
14(1): 8-17, 2016 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26733551
3.
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.
Lancet Oncol;
16(9): 1037-1048, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26272770
4.
Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
N Engl J Med;
366(4): 310-20, 2012 Jan 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22276821
5.
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations.
J Clin Oncol;
41(3): 618-628, 2023 01 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36288512
6.
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
Lancet;
371(9610): 395-403, 2008 Feb 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18242413